Scilex appoints Stephen Ma as COO; he continues as CFO

Scilex Holding Co

Stephen Ma, 53, appointed COO effective Oct 1, 2025; retains CFO, SVP, Corporate Secretary, and Board roles.
Ma has 15+ years finance/operations experience in pharma and venture-backed biotech.
Also appointed CFO of Semnur Pharmaceuticals (OTC:SMNR) on Sep 22, 2025.
No change in compensation for his COO appointment; standard indemnification agreement in place.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.